Drug Abuse: CLAAD Lauds Signature Therapeutics’ R&D Efforts to Reduce Prescription Drug Abuse

CLAAD Lauds Signature Therapeutics’ R&D Efforts To Reduce Prescription Drug Abuse
Filed under: Drug Abuse

WASHINGTON, July 12, 2013 /PRNewswire-USNewswire/ — The Center for Lawful Access and Abuse Deterrence (CLAAD) praised Signature Therapeutics, Inc. today for taking a national lead in biopharmaceutical research and development to reduce prescription drug abuse. Signature Therapeutics is a privately held company developing next-generation abuse-deterrent prescription medications. More than 2.7 …
{Source}

Pill disposal program aims to stop drug abuse

According to the federal government, the number one cause of accidental death in the U.S. is no longer car accidents — it’s drugs. Jim Axlerod reports on a …